Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Non-cash Items: 2022-2024

Historic Non-cash Items for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Dec 2024 value amounting to $2.9 million.

  • Phathom Pharmaceuticals' Non-cash Items fell 91.29% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 91.29%. This contributed to the annual value of $2.9 million for FY2024, which is 27.84% up from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Non-cash Items stood at $2.9 million for FY2024, which was up 27.84% from $2.3 million recorded in FY2023.
  • In the past 5 years, Phathom Pharmaceuticals' Non-cash Items registered a high of $2.9 million during FY2024, and its lowest value of $2.3 million during FY2023.
  • For the 3-year period, Phathom Pharmaceuticals' Non-cash Items averaged around $2.5 million, with its median value being $2.5 million (2022).
  • Per our database at Business Quant, Phathom Pharmaceuticals' Non-cash Items decreased by 7.47% in 2023 and then rose by 27.84% in 2024.
  • Phathom Pharmaceuticals' Non-cash Items (Yearly) stood at $2.5 million in 2022, then decreased by 7.47% to $2.3 million in 2023, then grew by 27.84% to $2.9 million in 2024.